sequence id,run,hcv_wg_pipeline,pipeline_version,sample id,sample date,initial genotype,genotype,subtype,Genotyping CORE,Genotyping E1,Genotyping E2,Genotyping P7,Genotyping NS2,Genotyping NS3,Genotyping NS4A,Genotyping NS4B,Genotyping NS5A,Genotyping NS5B,patient id,treatment id,regime,treatment date,drug id,drug manufacturer,therapy class,city,country of birth,date of birth,diagnosis date,ethnicity,nationality,gender,hiv status
H211520043-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520043,07-Jan-2021,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,13,,,,,,,London,England,27-Feb-2046,12-Jul-1992,White,British,Male,No
H211520439-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520439,08-Jan-2020,-,2,b,2b,2b,2b,2b,2b,2b,2b,2b,2b,2b,118,,,,,,,-,-,02-Nov-2067,28-Aug-1992,White,Others,Male,Yes
H211420369-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211420369,26-Sep-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,235,,,,,,,-,Russia,14-Feb-2058,23-Dec-1997,White,Russian,Unknown,Yes
H211420370-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211420370,07-Dec-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,236,,,,,,,-,Korea,09-Mar-2058,21-Sep-1996,White,Korean,Unknown,No
H211420371-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211420371,17-Sep-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,237,,,,,,,-,Ireland,13-Jan-1976,11-Jul-1994,White,Irish,Unknown,No
H211420372-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211420372,22-Jun-2020,-,4,k,4k,4k,4k,4k,4k,4k,4k,4k,4k,4k,238,,,,,,,-,Ireland,06-Feb-2062,22-Jun-2002,White,Irish,Other,Yes
H211420373-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211420373,09-Aug-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,239,,,,,,,-,Spain,02-Feb-2063,06-Mar-2004,White,Spanish,Female,No
H211420374-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211420374,06-Oct-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,240,,,,,,,-,France,26-Aug-2053,13-Jul-2003,Other/Mixed,French,Other,Yes
H211420375-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211420375,12-Jun-2019,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,241,,,,,,,London,Scotland,26-Dec-1974,12-Nov-1996,White,British,Male,-
H211420376-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211420376,26-Jul-2019,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,242,,,,,,,London,Gibraltar,29-Sep-1989,25-Mar-1990,White,British,Male,-
H211440767-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211440767,16-Feb-2021,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,243,,,,,,,-,Cuba,14-Nov-2057,30-Aug-1992,White,Cuban,Female,Yes
H211440768-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211440768,30-May-2019,-,Check genotyping results by genes: NULL 2b,-,,2b,,2b,2b,2b,2b,2b,,,244,,,,,,,Cambridge,Ghana,10-Mar-1988,19-Jun-1989,Not Stated,British,Female,Yes
H211440769-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211440769,22-Jul-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,245,,,,,,,-,England,02-Jul-2047,17-Jul-1996,White,British,Female,Yes
H211440770-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211440770,11-Sep-2020,-,Check genotyping results by genes: NULL 1b,-,,,,,,1b,1b,,,,246,,,,,,,Oxford,Brazil,28-Mar-1987,29-Oct-1991,White,Brazilian,Female,No
H211460729-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211460729,02-Sep-2019,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,247,,,,,,,London,Portugal,08-Aug-2054,14-Oct-1994,-,Portuguese,Male,-
H211480307-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211480307,11-Jul-2020,-,Check genotyping results by genes: NULL 3 3a,-,,,3,,3a,3a,,3a,3a,3a,248,,,,,,,-,England,10-Jun-1972,01-Oct-1993,White,British,Other,Yes
H211480619-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211480619,01-Jul-2019,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,249,,,,,,,-,China,01-Sep-1980,26-Jan-1988,White,Chinese,Male,No
H211480620-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211480620,23-Dec-2019,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,250,,,,,,,-,USA,20-Apr-2064,10-Jun-2004,White,British,Male,Yes
H211480621-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211480621,15-Feb-2021,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,251,,,,,,,-,Russia,01-Sep-2055,16-Aug-2002,Not Stated,Russian,Male,Yes
H211480623-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211480623,02-Sep-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,252,,,,,,,-,Korea,17-Jul-2067,01-Apr-1998,White,Korean,Male,Yes
H211480624-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211480624,04-Jan-2021,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,253,,,,,,,-,Ireland,21-May-2062,21-Apr-1995,Asian,Irish,Female,Yes
H211480625-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211480625,11-Jul-2019,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,254,,,,,,,London,Ireland,29-Jun-1983,30-Sep-1990,White,Irish,Male,Yes
H211480669-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211480669,06-May-2020,3b,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,255,46.0,1 tablet per day,05-Jun-2019,ritonavir,AbbVie,NS5A inhibitor,-,Spain,30-Oct-2050,26-Apr-1988,Other/Mixed,Spanish,Unknown,Yes
H211500319-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211500319,13-Feb-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,256,,,,,,,-,France,12-Oct-2068,27-Jan-1989,White,French,Other,No
H211500410-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211500410,29-Jun-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,257,,,,,,,-,Scotland,04-Nov-2053,02-Nov-1995,White,British,Other,No
H211500411-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211500411,12-Feb-2021,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,258,,,,,,,-,Gibraltar,23-Oct-1972,19-Mar-1998,White,British,Other,Yes
H211520034-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520034,07-Jan-2021,-,Check genotyping results by genes: 1 1b,-,1,1b,1b,1b,1b,1b,1b,1b,1b,1b,259,,,,,,,-,Cuba,21-Jan-1972,23-Jul-1988,Not Stated,Cuban,Other,No
H211520035-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520035,15-Dec-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,260,,,,,,,London,Ghana,13-May-1981,06-Mar-2004,White,British,Male,Yes
H211520036-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520036,16-Feb-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,261,,,,,,,-,England,16-Apr-2068,12-Nov-1992,Black African,British,Male,Yes
H211520037-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520037,15-May-2019,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,262,47.0,2 tablets per day,08-Oct-2020,simeprevir,Janssen,NS3A/4A protease inhibitor,-,Brazil,29-Aug-1975,08-Jul-1990,Not Stated,Brazilian,Other,Yes
H211520038-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520038,20-Apr-2019,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,263,,,,,,,London,Portugal,15-Jul-2050,03-Jun-2004,Asian,Portuguese,Other,Yes
H211520039-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520039,17-Jan-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,264,,,,,,,London,England,14-May-2046,24-Dec-1997,White,British,Unknown,Yes
H211520041-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520041,23-Jan-2020,-,Check genotyping results by genes: 1a 1,-,1a,1a,1a,1a,1a,1a,1,1a,1a,1a,265,48.0,2 tablets per day,07-Feb-2011,simeprevir,Janssen,NS3A/4A protease inhibitor,Manchester,China,20-Aug-2065,22-Sep-1996,White,Chinese,Female,Yes
H211520042-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520042,19-Mar-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,266,,,,,,,London,USA,26-May-1987,11-Aug-1994,Other/Mixed,British,Female,No
H211520052-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520052,08-May-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,268,49.0,1 tablet per day,05-Mar-1988,simeprevir,Janssen,NS3A/4A protease inhibitor,Salisbury,Russia,07-Nov-2057,23-Jun-2002,Other/Mixed,Russian,Female,No
H211520425-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520425,18-Sep-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,269,,,,,,,-,Korea,28-Dec-2066,06-Apr-2004,Not Stated,Korean,Other,Yes
H211520426-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520426,18-May-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,270,,,,,,,-,Ireland,25-Aug-2045,14-Jul-2003,Other/Mixed,Irish,Female,No
H211520427-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520427,15-Apr-2019,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,271,65.0,2 tablets per day,07-Jan-2011,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,-,Ireland,20-Dec-2061,12-Dec-1996,Not Stated,Irish,Male,Yes
H211520428-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520428,30-Dec-2019,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,272,,,,,,,London,Spain,23-Oct-1981,17-Aug-2002,Not Stated,Spanish,Unknown,Yes
H211520429-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520429,26-Mar-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,273,,,,,,,-,France,05-Dec-1973,31-Aug-1992,Other/Mixed,French,Male,Yes
H211520430-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520430,12-Jan-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,274,,,,,,,London,Scotland,17-Apr-2067,20-Jun-1989,White,British,Unknown,Yes
H211520431-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520431,08-Sep-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,275,,,,,,,-,Gibraltar,24-Sep-2052,18-Jul-1996,White,British,Male,Yes
H211520432-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520432,10-Oct-2019,3a,4,w,4w,4w,4w,4w,4w,4w,4w,4w,4w,4w,276,,,,,,,London,Cuba,09-Sep-1971,30-Oct-1991,Other/Mixed,Cuban,Male,Yes
H211520433-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520433,01-May-2019,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,277,50.0,1 tablet per day,07-Feb-2011,ledipasvir,Gilead,NS5A inhibitor,-,Ghana,01-Aug-2053,15-Oct-1994,White,British,Other,No
H211520434-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520434,24-Mar-2021,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,278,,,,,,,London,England,16-Sep-2043,01-Nov-1993,White,British,Other,No
H211520435-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520435,31-Mar-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,279,,,,,,,-,Brazil,16-May-2048,27-Jan-1988,White,Brazilian,Female,Yes
H211520437-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520437,01-Jun-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,280,,,,,,,-,Portugal,26-Dec-1977,10-Jul-2004,White,Portuguese,Unknown,No
H211520438-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520438,17-May-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,281,51.0,-,05-Jun-2019,paritaprevir,AbbVie,NS3A/4A protease inhibitor,-,England,11-Sep-2051,17-Aug-2002,White,British,Unknown,Yes
H211520441-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520441,22-Oct-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,283,,,,,,,-,China,13-Jun-1977,01-May-1998,White,Chinese,Male,Yes
H211520812-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520812,19-Feb-2021,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,284,,,,,,,London,USA,08-Nov-1987,22-Apr-1995,White,British,Male,Yes
H211520813-1_NGS97,NGS97,PHE HCV bioinformatics pipeline,version 1.0,H211520813,19-Sep-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,285,,,,,,,London,Russia,20-Apr-1974,10-Jan-1990,Black African,Russian,Unknown,Yes
